Search

Medtronic PLC

Cerrado

SectorSanidad

89.03 1.92

Resumen

Variación precio

24h

Actual

Mínimo

85.47

Máximo

88.46

Métricas clave

By Trading Economics

Ingresos

206M

1.5B

Ventas

-51M

9.8B

P/B

Media del Sector

21.614

47.946

BPA

1.45

Rentabilidad por dividendo

3.3

Margen de beneficios

15.16

Empleados

95,000

EBITDA

-682M

2B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+20.25% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

3.30%

2.27%

Próximas Ganancias

17 nov 2026

Fecha Próximo Dividendo

16 oct 2026

Próxima Fecha de Ex Dividendo

25 dic 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-3.5B

113B

Apertura anterior

87.11

Cierre anterior

89.03

Noticias sobre sentimiento de mercado

By Acuity

18%

82%

33 / 340 Clasificación en Healthcare

Medtronic PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 oct 2026, 22:51 UTC

News

Medtronic PLC announced an exchange ratio of 4.5939 shares of MiniMed Group, Inc. stock for each ordinary share, contributing to a modest gain in after-market trading.

6 oct 2026, 22:40 UTC

Medtronic PLC is recovering in after-market trading, rising sharply from Tuesday's close and reaching its highest level of the day, despite remaining below its 20-day moving average.

5 oct 2026, 21:01 UTC

Medtronic PLC traded roughly flat during after-market hours, closing near the lower end of its one-month range and below its 20-day moving average.

3 oct 2026, 00:00 UTC

Medtronic PLC shares traded modestly higher in after-market hours on Friday, recovering from a brief dip and remaining near the lower end of their one-month trading range.

2 oct 2026, 23:00 UTC

Medtronic PLC is advancing in after-market trading, showing a modest increase since Friday's close, with significant upward movement shortly after the market reopened.

1 oct 2026, 22:01 UTC

News

Medtronic PLC shares are higher in after-market trading following the approval of new CPT codes for its Altaviva and Symplicity Spyral devices, effective January 2028.

30 sept 2026, 23:01 UTC

Medtronic PLC is trading modestly higher in after-market hours, reflecting broader market trends amid positive economic indicators and stronger-than-expected private sector job growth.

29 sept 2026, 20:02 UTC

Medtronic PLC shares fell sharply today, reversing a trend of higher daily closes, amid unusually high trading volume and broader market trends.

28 sept 2026, 23:16 UTC

Medtronic PLC is trading slightly lower in after-market hours, remaining below its 20-day moving average and near the lower end of its one-month range.

25 sept 2026, 23:50 UTC

Medtronic PLC is down in after-market trading, continuing a seven-session trend of lower finishes and remaining significantly below its 20-day moving average.

23 sept 2026, 20:03 UTC

News

Medtronic PLC shares fell sharply, continuing a downward trend with five consecutive losses, despite solid first-quarter results and raised full-year guidance.

22 sept 2026, 23:21 UTC

Medtronic PLC is trading modestly higher in after-market hours, stabilizing after an initial decline amid broader market weakness.

21 sept 2026, 19:46 UTC

News

Medtronic PLC shares fell as the company raised its adjusted profit forecast and reported revenue growth for Q1 fiscal 2027, despite FDA clearance for its LigaSure device.

18 sept 2026, 23:06 UTC

News

Medtronic PLC raised its fiscal 2027 profit forecast and reported first-quarter revenue of $9.756 billion, exceeding expectations, in after-market trading.

17 sept 2026, 23:06 UTC

Medtronic PLC is trading modestly higher in after-market hours, remaining near the upper end of its one-month range following Thursday's close.

16 sept 2026, 23:01 UTC

Event

Medtronic PLC's LigaSure™ RAS Maryland jaw device received FDA clearance, but the stock is modestly lower in after-market trading since Wednesday's close.

15 sept 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market hours, tracking broader market gains. No specific company news was identified to influence this movement.

14 sept 2026, 23:06 UTC

Medtronic PLC shares are lower in after-market hours amid a U.S. market decline linked to rising crude oil prices and supply concerns.

11 sept 2026, 22:52 UTC

Medtronic PLC shares are lower in after-market hours, continuing recent downward momentum and trading below the 20-day moving average.

10 sept 2026, 23:56 UTC

Medtronic PLC shares are lower in after-market hours, continuing a trend from recent sessions. Volatility marked today's trading, with no specific news identified.

9 sept 2026, 22:02 UTC

Social Media

Medtronic PLC has been recognized by Morningstar as a top dividend stock, with shares moving higher in after-market trading since Wednesday's close.

8 sept 2026, 23:01 UTC

Medtronic PLC shares are trading higher in after-market hours, reflecting notable fluctuations during the session and remaining near the upper end of their one-month range.

4 sept 2026, 23:16 UTC

Shares of Medtronic PLC are higher in after-market hours, despite earlier declines. The stock remains above its 20-day moving average.

3 sept 2026, 23:01 UTC

Medtronic PLC shares declined in after-market trading, reversing gains from earlier sessions. No specific news was identified to explain the price movement.

2 sept 2026, 23:06 UTC

Medtronic PLC shares are trading higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month trading range.

1 sept 2026, 23:06 UTC

Medtronic PLC shares declined during after-market hours, showing notable volatility. The price remains above its 20-day moving average and near the one-month range's upper end.

31 ago 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market trading, positioned about 1.01% above their 20-day moving average. No specific news was identified for the movement.

29 ago 2026, 00:06 UTC

Medtronic PLC shares advanced in after-market trading, fluctuating amid broader market expectations for interest rate hikes and ongoing inflation concerns.

28 ago 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market trading, with no specific news identified. The stock remains above its 20-day moving average.

27 ago 2026, 23:02 UTC

Medtronic PLC shares advanced in after-market trading, recovering from earlier volatility. Broader market context includes a decline in initial jobless claims.

Comparación entre iguales

Cambio de precio

Medtronic PLC previsión

Precio Objetivo

By TipRanks

20.25% repunte

Estimación a 12 Meses

Media 102.824 USD  20.25%

Máximo 118 USD

Mínimo 85 USD

De acuerdo con 20 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Medtronic PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

20 ratings

11

Comprar

9

Mantener

0

Vender

Sentimiento

By Acuity

33 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.